|
Market Closed -
Nasdaq
21:00:00 09/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.3301 USD | -4.26% |
|
-13.38% | -66.99% |
| 09-02 | Needham Downgrades TScan Therapeutics to Hold From Buy | MT |
| 09-02 | Wedbush Downgrades TScan Therapeutics to Neutral From Outperform, Adjusts Price Target to $1 From $5 | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -4.26% | -13.38% | -58.54% | -65.81% | -66.99% | -82.06% | -86.30% | -96.05% | - | 23.37M | |
| -0.94% | -0.71% | +0.04% | +65.68% | +70.87% | +45.60% | +103.25% | +10.02% | - | 69.19B | |
| -0.07% | -3.93% | +13.36% | +14.14% | +20.70% | +32.54% | +78.50% | +205.72% | +5,887.54% | 62.97B | |
| +3.13% | +1.71% | -1.75% | +30.05% | -25.99% | -12.50% | +390.48% | +357.71% | +877.24% | 27.27B | |
| -0.54% | -5.47% | +4.76% | +13.45% | +3.08% | -3.88% | -18.31% | -72.07% | - | 24.78B | |
| -1.19% | -5.01% | +4.42% | +62.15% | +53.18% | +28.09% | +12.79% | -59.39% | - | 25.8B | |
| -1.43% | -1.89% | +6.75% | +32.51% | +5.28% | +21.32% | -19.01% | -25.36% | +113.40% | 20.11B | |
| -4.27% | +3.07% | +8.47% | +50.70% | +217.44% | +211.22% | +362.48% | +1,697.71% | +830.17% | 18.47B | |
| -1.33% | -4.35% | -10.09% | +18.39% | +21.16% | -5.05% | +508.45% | - | - | 14.88B | |
| +1.14% | -0.34% | +7.88% | +10.08% | +33.08% | +52.38% | +163.82% | +198.52% | +386.89% | 14.29B | |
| +1.50% | +20.14% | +25.64% | +22.74% | +0.29% | -6.83% | +1,038.96% | +166.16% | +183.82% | 13.79B | |
| +2.34% | -0.05% | +7.18% | +14.63% | -6.13% | +21.82% | +178.09% | +582.39% | +4,838.21% | 12.34B | |
| -2.91% | -3.21% | -5.73% | +12.68% | +24.46% | +197.98% | +176.35% | +26.56% | +1,054.05% | 12.02B | |
| +0.58% | +4.85% | -6.21% | +8.24% | -15.75% | -28.69% | +158.34% | +116.36% | - | 11.3B | |
| -1.65% | +3.03% | -3.45% | +8.27% | +16.64% | +43.90% | +105.52% | +146.62% | +715.29% | 10.48B | |
| -1.41% | -3.36% | +2.48% | +26.94% | +28.98% | +81.88% | +17.42% | +128.97% | - | 8.98B | |
| -2.77% | +1.38% | +5.50% | +11.17% | +307.07% | +213.62% | +524.81% | -18.99% | - | 8.79B | |
| -1.75% | -7.02% | -10.91% | +7.86% | +4.86% | -25.54% | +100.00% | -28.23% | - | 8.54B | |
| -4.25% | -0.14% | -17.14% | +13.72% | +165.35% | +419.30% | +520.93% | -51.03% | -49.97% | 8.01B | |
| -5.02% | +14.00% | +12.33% | +29.51% | +14.50% | +178.87% | +481.28% | - | - | 7.77B | |
| Average | -1.24% | +2.28% | -0.75% | +19.36% | +43.60% | +69.20% | +239.89% | +182.53% | +1,483.66% | 18.99B | |
| Weighted average by Cap. | -0.69% | +0.90% | +3.91% | +30.99% | +43.47% | +53.51% | +194.56% | +186.92% | +2,502.36% |
- Stock Market
- Stocks
- TCRX Stock
- Sector TScan Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
